Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy

Clinical trial NCT03640481 · TERMINATED

Trial details

NCT number: NCT03640481
Sponsor: Kadmon, a Sanofi Company
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Graft-versus-host-disease

Start date: 2018-10-11
Primary completion: 2023-12-11
Enrollment: 159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.